122 related articles for article (PubMed ID: 9231173)
1. Basaloid squamous cell carcinoma of the maxilla.
Wedenberg C; Jesslén P; Lundqvist G; Lundgren J; Hellquist HB
Oral Oncol; 1997 Mar; 33(2):141-4. PubMed ID: 9231173
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region.
Yu GY; Gao Y; Peng X; Chen Y; Zhao FY; Wu MJ
Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1003-8. PubMed ID: 18632253
[TBL] [Abstract][Full Text] [Related]
3. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
Kushner J; Bradley G; Jordan RC
J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
[TBL] [Abstract][Full Text] [Related]
4. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.
Linskey KR; Gimbel DC; Zukerberg LR; Duncan LM; Sadow PM; Nazarian RM
Arch Pathol Lab Med; 2013 Nov; 137(11):1591-8. PubMed ID: 24168496
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen immunoreactivity and the presence of P53 mutation in basaloid squamous cell carcinoma of the larynx.
Akyol MU; Dursun A; Akyol G; Edaliota N
Oncology; 1998; 55(5):382-3. PubMed ID: 9732213
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
7. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations.
Lo Muzio L; Mignogna MD; Pannone G; Rubini C; Grassi R; Nocini PF; Ferrari F; Serpico R; Favia G; De Rosa G; Maiorano E
Oncol Rep; 2003; 10(2):285-91. PubMed ID: 12579259
[TBL] [Abstract][Full Text] [Related]
10. [Basaloid squamous cell carcinoma: clinical pathological and immunohistochemical study].
Gao Y; Liu X; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Sep; 33(5):290-1. PubMed ID: 11774658
[TBL] [Abstract][Full Text] [Related]
11. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
Smith KJ; Williams J; Corbett D; Skelton H
Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
[TBL] [Abstract][Full Text] [Related]
12. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
13. Proliferation and apoptosis within the oral mucosa "hemangiomas".
Dyduch G; Okoń K
Pol J Pathol; 2000; 51(2):93-6. PubMed ID: 10974933
[TBL] [Abstract][Full Text] [Related]
14. Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma.
Albuquerque RL; Miguel MC; Costa AL; Souza LB
Int J Exp Pathol; 2003 Dec; 84(6):259-65. PubMed ID: 14748745
[TBL] [Abstract][Full Text] [Related]
15. [Basaloid squamous epithelial carcinoma (basaloid-squamous carcinoma) of the mouth floor. Differential diagnosis and response to neoadjuvant chemotherapy].
Strassburger S; Hyckel P; Schumann D; Berndt A; Kosmehl H
Mund Kiefer Gesichtschir; 1997 Jul; 1(4):239-43. PubMed ID: 9410634
[TBL] [Abstract][Full Text] [Related]
16. Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas.
Pereira CH; Morais MO; Martins AF; Soares MQ; Alencar Rde C; Batista AC; Leles CR; Mendonça EF
Arch Oral Biol; 2016 Jan; 61():8-15. PubMed ID: 26476747
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin subtypes: MMP-9, p53, and αSMA to differentiate basaloid squamous cell carcinoma from other basaloid tumors of the oral cavity.
Mane DR; Kale AD; Angadi P; Hallikerimath S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):431-43. PubMed ID: 23343955
[TBL] [Abstract][Full Text] [Related]
18. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
[TBL] [Abstract][Full Text] [Related]
19. Basaloid squamous cell carcinoma of the oral mucosa: a new case and review of 45 cases in the literature.
Ide F; Shimoyama T; Horie N; Kusama K
Oral Oncol; 2002 Jan; 38(1):120-4. PubMed ID: 11755833
[TBL] [Abstract][Full Text] [Related]
20. Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.
Sarbia M; Loberg C; Wolter M; Arjumand J; Heep H; Reifenberger G; Gabbert HE
Am J Pathol; 1999 Oct; 155(4):1027-32. PubMed ID: 10514383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
